Last reviewed · How we verify
NCT03636048
Comparison of Anesthesia Type in Patients Undergoing Transabdominal Cervico Isthmic Cerclage (TCIC)
NA trial testing Bupivacaine Hcl 0.5% Inj in Cervical Incompetence in 20 participants. Terminated before completion.
1 June 2020
Quick facts
| Lead sponsor | Hallym University Kangnam Sacred Heart Hospital |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 20 |
| Start date | 1 August 2018 |
| Primary completion | 1 June 2020 |
| Estimated completion | 1 June 2020 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Bupivacaine Hcl 0.5% Inj — full drug profile →
- Propofol 10 milligram/ML — full drug profile →
Conditions studied
- Cervical Incompetence — all drugs for Cervical Incompetence →
Sponsor
Hallym University Kangnam Sacred Heart Hospital
Who can join
Adults 20 to 50, female only, with Cervical Incompetence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigator aimed to compare the effect of anesthesia on overall postoperative outcomes including post-operative pain score and the fetal well-being (heart rate) in patients undergoing transabdominal cervico isthmic cerclage(TCIC). The investigator divided the patients into two groups. The first group was the patients who undergo general anesthesia with postoperative wound patient-controlled analgesia device(PCA) and the second group was the patients who undergo combined spinal-epidural anesthesia(CSE) with postoperative epidural catheter PCA device for pain control.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03636048
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bupivacaine Hcl 0.5% Inj
Trials testing the same drug.
- NCT06958718 — Ultrasound vs. Surgical ESP Block With Bupivacaine-Dexmedetomidine in Lumbar Fusion Surgery · Phase 4 · completed
- NCT06575010 — Exparel v Dexamethasone in RCR · Phase 4 · enrolling by invitation
- NCT05998551 — Single Shot Intrathecal Analgesia in Vaginal Delivery · NA · unknown
- NCT04737980 — Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve · Phase 4 · completed
Other Hallym University Kangnam Sacred Heart Hospital trials
Trials by the same sponsor.
- NCT05671978 — Head Elevated Position and Hyper-angulated Video-laryngoscope Guided Intubation · NA · completed
- NCT07247071 — Modifiable Risk Factors for Non-traumatic Subconjunctival Hemorrhage · completed
- NCT05302258 — Attenuation Imaging in Hepatic Steatosis · unknown
- NCT05303155 — The Association of Gut Microbiota With COVID 19 Infection in Children · unknown
- NCT04615689 — The Association of Gut Microbiota With Urinary Tract Infection in Infants · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03636048 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hallym University Kangnam Sacred Heart Hospital
- Last refreshed: 4 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03636048.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing